skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

 

#Drive Toward a Cure…#Cocktails for a Cause…#Madison Reprom…#Knoxville Yogafest…#Hoop-a-thon…#CHDI HD Therapeutics Conference…what do all of these have in common? All are events aimed towards raising money and/or sharing research to help people who have Huntington’s disease.

 

 

Huntington’s disease is a genetic disease with symptoms that begin to present between 30 and 50 years of age. The symptoms, which may include uncontrolled movements, loss of intellectual faculties and emotional disturbance, worsen over a 10 to 25 year period. This disease is devastating both to those experiencing the disease, and also to family members, both as caretakers and eventual patients, if they carry the expanded gene.

 

 

Considering the gravity of Huntington’s disease, what is going on in Huntington’s disease research to help these people?

 

 

Data from Pharmaprojects (Fig. 1) shows a promising number of industry-sponsored pipeline therapies for Huntington’s, including 4 compounds that have reached the final stages of clinical testing. There are also over 32 compounds in preclinical development, which suggests that more clinical activity could occur in the near future.

 

 

Huntington-disease-blog-chart

 

 

Data from Trialtrove (Fig. 2) shows a lot of current activity, as shown by the number of open or planned trials.

 

 

Huntington-disease-blog-chart-2

 

 

Fig. 3 provides a view of the companies that are most active in the Huntington’s space, as evidenced by having more than a single drug project for this disease.  It is interesting to note that private foundations have been important in promoting research, as is the case for some other rare diseases, such as, Parkinson’s disease, and cystic fibrosis.  For example, Pharmaprojects data illustrates how the CHDI Foundation is currently collaborating with industry partners on the development of multiple compounds for Huntington’s disease.

 

 

Huntington-disease-blog-chart-3

 

 

The activity in Huntington’s disease research means potential promise for those with this disease.  Day-by-day, hand-in-hand, a difference can truly be made.  Let me know how you are you involved in making a difference in Huntington’s disease. February 28th is #RareDiseaseDay, please let yourself be heard!

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。